Femasys FEMY
NASDAQ FEMY
$2.83 +0.15 (+5.60%)
At close: Sep 9, 2026 · 4:00 PM EDT

Femasys (FEMY) Shares Outstanding (2020 - 2026)

Femasys' (FEMY) quarterly Shares Outstanding (Entity) came in at $3.0 million in Q2 2026, up 85.66% on a YoY basis from $1.6 million in Q2 2025, and little changed quarter-over-quarter from $3.0 million in Q1 2026.

Analysis

Femasys (FEMY) Shares Outstanding (2020 - 2026) Analysis & Trends

Femasys (FEMY) has reported Shares Outstanding (Entity) for 7 consecutive years, with $3.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Shares Outstanding (Entity) rose 85.66% year-over-year to $3.0 million; the trailing twelve-month figure through Jun 2026 stood at $3.0 million (up 85.66% YoY), and the FY2025 full-year result was $2.0 million, up 69.33% from the prior year.
  • Shares Outstanding (Entity) held at $3.0 million in Q2 2026 per FEMY's latest filing, from $3.0 million in the prior quarter.
  • Across five years, Shares Outstanding (Entity) topped out at $3.0 million in Q2 2026 and bottomed at $590208.0 in Q1 2022.
  • Historically, Shares Outstanding (Entity) has averaged $1.3 million across 5 years, with a median of $1.1 million in 2024.
  • The widest YoY moves for Shares Outstanding (Entity): up 961.11% in 2022, down 0.12% in 2022.
  • Over 5 years, Shares Outstanding (Entity) stood at $593485.0 in 2022, then advanced by 29.61% to $769219.0 in 2023, then jumped by 51.82% to $1.2 million in 2024, then soared by 69.33% to $2.0 million in 2025, then surged by 52.92% to $3.0 million in 2026.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $3.0 million, $3.0 million, and $2.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn 1.74 Bn
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn 354.10 Mn
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn 1.28 Bn
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn 383.50 Mn
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn 1.47 Bn
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn 576.40 Mn
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn 493.20 Mn
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn 382.20 Mn
9 Steris 21.90 Bn 21.43 Bn 684.20 Mn 97.60 Mn
10 Femasys 9.01 Mn 7.57 Mn 189,391.00 3.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.36 Mn
Mar 31, 2026 3.33 Mn
Dec 31, 2025 1.98 Mn
Sep 30, 2025 2.05 Mn
Jun 30, 2025 1.44 Mn
Mar 31, 2025 1.26 Mn
Dec 31, 2024 1.11 Mn
Sep 30, 2024 1.11 Mn
Jun 30, 2024 1.11 Mn
Mar 31, 2024 1.09 Mn
Dec 31, 2023 769,219.00
Sep 30, 2023 754,657.00
Jun 30, 2023 655,380.00
Mar 31, 2023 593,613.00
Dec 31, 2022 590,751.00
Sep 30, 2022 590,680.00
Jun 30, 2022 590,649.00
Mar 31, 2022 590,208.00
Dec 31, 2021 335,601.00
Sep 30, 2021 589,986.00